Peripheral Artery Disease (PAD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Peripheral Artery Disease Marketed and Pipeline Drugs Report Overview
PAD is an atherosclerotic disease in which the formation of atherosclerotic plaque causes narrowing of the arteries and poor perfusion to the limbs. This can progress to arterial occlusion and chronic limb-threatening ischemia (CLTI). PAD can happen in any blood vessel, but it is more common in the legs than the arms.
Key Mechanisms of Action (Marketed) | · Receptor Agonist
· Enzyme Inhibitor · Biological Factor Activator · Ligand Inhibitor · Receptor Antagonist |
Key Molecule Types (Marketed) | · Small Molecule
· Biologic |
Key Routes of Administration (Marketed) | · Oral
· Injection · Topical · Inhalational |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
The Peripheral Artery Disease Marketed and Pipeline Drugs Market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and pricing and reimbursement of therapy in major countries. Furthermore, the report analyzes late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for Peripheral Artery Disease.
The report also provides actionable insights into the clinical and commercial landscapes of Peripheral Artery Disease drugs, M&A deals, and market catalysts. These critical data will help you develop and design your in-licensing and out-licensing strategies. Furthermore, identify companies with the most robust pipelines to create smart business goals.
Key Mechanisms of Action (Pipeline) | · Enzyme Inhibitor
· Biological Factor Inhibitor · Receptor Antagonist · Protein & Peptide Inhibitor · Receptor Agonist · Enzyme Activator |
Key Molecule Types (Pipeline) | · Biologic
· Small Molecule · Oligonucleotide |
Key Routes of Administration (Pipeline) | · Injection
· Oral · Topical · Inhalational |
Top Sponsors (Marketed and Pipeline Drugs) | · Northwestern University
· Yonsei University · Shenzhen Salubris Pharmaceuticals · Pharmtechnology LLC · Atoll · Novartis AG |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Peripheral Artery Disease Marketed Drugs Market Segmentation by Mechanisms of Action
The key MoA of the marketed drugs for Peripheral Artery Disease include receptor agonist, enzyme inhibitor, biological factor activator, ligand inhibitor, and receptor antagonist among others. Most of the marketed drugs followed receptor antagonist MoA in 2023 in the Peripheral Artery Disease market.
Peripheral Artery Disease Marketed Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Peripheral Artery Disease Marketed Drugs
Peripheral Artery Disease Marketed Drugs Market Segmentation by Routes of Administration
The key RoA of Peripheral Artery Disease marketed drugs include oral, injection, topical, and inhalational. Most marketed drugs that were available for Peripheral Artery Disease were oral therapies, followed by injectables.
Peripheral Artery Disease Marketed Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of Peripheral Artery Disease Marketed Drugs
Peripheral Artery Disease Marketed Drugs Market Segmentation by Molecule Types
In 2023, the leading molecule type for Peripheral Artery Disease marketed drugs was small molecule followed by biologic.
Peripheral Artery Disease Marketed Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Peripheral Artery Disease Marketed Drugs
Peripheral Artery Disease Pipeline Drugs Market Segmentation by Mechanisms of Action
The key MoA of the drugs in the Peripheral Artery Disease pipeline mainly include enzyme inhibitor, biological factor inhibitor, receptor antagonist, protein & peptide inhibitor, receptor agonist, and enzyme activator among others. Most of the pipeline drugs undergoing development for PAD followed receptor agonist MoA in 2023.
Peripheral Artery Disease Pipeline Drugs Market Analysis by Mechanisms of Action, 2023 (%)
Buy the Full Report to Know More about the MoA of Peripheral Artery Disease Pipeline Drugs
Peripheral Artery Disease Pipeline Drugs Market Segmentation by Routes of Administration
The key RoA of the drugs in the Peripheral Artery Disease pipeline mainly include injection, oral, topical, and inhalational. In 2023, most pipeline drugs that were under development for Peripheral Artery Disease were injection therapies.
Peripheral Artery Disease Pipeline Drugs Market Analysis by Routes of Administration, 2023 (%)
Buy the Full Report to Know More about the RoA of Peripheral Artery Disease Pipeline Drugs
Peripheral Artery Disease Pipeline Drugs Market Segmentation by Molecule Types
In 2023, the leading molecule type for Peripheral Artery Disease pipeline drugs was biologic, followed by small molecule. A few of the PAD drugs currently in development are also oligonucleotide.
Peripheral Artery Disease Pipeline Drugs Market Analysis by Molecule Types, 2023 (%)
Buy the Full Report to Know More about the Molecule Types of Peripheral Artery Disease Pipeline Drugs
Peripheral Artery Disease Marketed and Pipeline Drugs Market - Competitive Landscape
A few of the top sponsors in Peripheral Artery Disease marketed and pipeline drugs market are Northwestern University, Yonsei University, Shenzhen Salubris Pharmaceuticals, Pharmtechnology LLC, Atoll, and Novartis AG among others. Northwestern University sponsored the highest number of trials in 2023. Roche conducted the highest number of Phase III trials, while the highest number of Phase II trials was sponsored by AbbVie.
Peripheral Artery Disease Marketed and Pipeline Drugs Market Analysis by Sponsors, 2023 (%)
Buy Full Report for More Sponsor Insights into the Peripheral Artery Disease Marketed and Pipeline Drugs Market
Segments Covered in the Report
Peripheral Artery Disease Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Enzyme Inhibitor
- Biological Factor Activator
- Ligand Inhibitor
- Receptor Antagonist
Peripheral Artery Disease Marketed Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologic
- Small Molecule
Peripheral Artery Disease Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Enzyme Inhibitor
- Biological Factor Inhibitor
- Receptor Antagonist
- Protein & Peptide Inhibitor
- Receptor Agonist
- Enzyme Activator
Peripheral Artery Disease Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Biologic
- Small Molecule
- Oligonucleotide
Scope
The key components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Understand the trends shaping and driving the Peripheral Artery Disease market to develop business strategies.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Peripheral Artery Disease market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
Which was the leading MoA for Peripheral Artery Disease marketed drugs in 2023?
Most of the drugs followed receptor antagonist MoA in 2023 in the Peripheral Artery Disease drugs market.
-
Which was the leading molecule type for Peripheral Artery Disease marketed drugs in 2023?
In 2023, most of marketed drugs for PAD were small molecules.
-
Which was the leading MoA for Peripheral Artery Disease pipeline drugs in 2023?
Most of the drugs followed receptor agonists MoA in 2023 in the Peripheral Artery Disease drugs market.
-
Which was the leading molecule type for Peripheral Artery Disease pipeline drugs in 2023?
In 2023, most of the drugs in development for Peripheral Artery Disease were biologics.
-
Who are the top sponsors in the Peripheral Artery Disease marketed and pipeline drugs market?
A few of the top sponsors in the Peripheral Artery Disease marketed and pipeline drugs market are Northwestern University, Yonsei University, Shenzhen Salubris Pharmaceuticals, Pharmtechnology LLC, Atoll, and Novartis AG among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.